This analysis revealed a marginal association between the RTK/ERK pathway genes including BAD (P = 0.058), PDGF-D (P = 0.051) and CCND2 (P = 0.052) and aggressive prostate cancer. The gene discussed is PDGFD; the disease is prostate carcinoma.